Scientists have made a key breakthrough in treating respiratory diseases by developing a new drug delivery system that ...

Lipid nanoparticles (LNP’s) came to prominence for delivery of RNA with the success of the Moderna and Pfizer BioNTech COVID-19 vaccines. They are also used to deliver therapeutic treatments including ...

A team led by scientists at the University of Nottingham's School of Pharmacy demonstrated a new cryogenic mass spectrometry approach for depth profiling frozen tiny lipid nanoparticles to reveal the ...

Researchers in Melbourne may have taken a major step toward an HIV cure after discovering a new way to unmask the virus ...

Lipid nanoparticles (LNP’s) came to prominence for delivery of RNA with the success of the Moderna and Pfizer BioNTech COVID-19 vaccines. They are also used to deliver therapeutic treatments ...

Scientists behind a world-first gene therapy reveal how they teamed up with experts across academia and industry to produce a ...

The tantalising development has been reported by researchers at the Peter Doherty Institute for Infection and Immunity in ...

Inhalable nanovaccines offer needle-free, mucosal immunity against respiratory diseases like COVID-19, influenza, and TB.

Short for messenger RNA, mRNA is a set of instructions for a gene ... Seeing the success of the Covid vaccines, which used lipid nanoparticles — tiny spheres of fat — containing mRNA, her team tested ...

We spoke to Örn Almarsson about the therapeutic potential of mRNA lipid nanoparticles and the techniques being used to ...

The global lipid nanoparticles market is on the cusp of remarkable expansion, projected to grow at a CAGR of 14% through 2035, according to a recent industry analysis. Estimated to generate USD 1,144.